arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2016 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    THERAPY FROM A CRITICAL VIEWPOINT

    Polypill with rosuvastatin, candesartan and hydrochlorothiazide failed for the time being

    NEW ON THE MARKET

    Mepolizumab (NUCALA) for severe refractory eosinophilic asthma

    Brivaracetam (BRIVIACT) against partial-onset seizures

    a-t READER'S QUESTIONS AND COMMENTS

    Vaccination against tick-borne encephalitis: how often to booster?

    Prophylactic antibiotics prior to procedures in patients with prosthetic joints?

    Oral g-strophanthin (ouabain) for heart patients?

    IN BRIEF

    Painkillers against uncomplicated cystitis?

    Olmesartan (OLMETEC, VOTUM) is no longer reimbursed in France

    Progressive multifocal leukoencephalopathy with dimethyl fumarate (TECFIDERA)

    CURRENT ADR NETWORK REPORT

    Tinnitus with topical green tea extract (VEREGEN)

    SIDE EFFECTS

    Abuse of the antihistamines diphenhydramine (e.g. EMESAN) and dimenhydrinate (e.g. VOMEX A)
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles